Acerca de
Nuestra Labor
Datos y herramientas
Eventos
Noticias
Alok-Srivastava-elected-to-BOD-2024

El doctor Alok Srivastava electo como miembro médico al consejo directivo de la FMH

La Federación Mundial de Hemofilia (FMH) tiene el enorme gusto de anunciar que el doctor Alok Srivastava fue electo como miembro médico al consejo directivo de la FMH en la reunión anual de la Asamblea General que tuvo lugar durante el Congreso Mundial 2024 de la FMH, en Madrid, España, para un periodo de cuatro años.

También disponible en: English Français

El doctor Alok Srivastava, hematólogo con más de tres décadas de experiencia, reside en Vellore, India. Actualmente es profesor titular en el Departamento de Hematología del Colegio Médico Cristiano en Vellore, India, y presidente de la Asociación India para la Hemofilia y Trastornos Afines. Srivastava detenta una licenciatura en medicina de la Universidad de Madrás, India, con especialidad en hematología.

Srivastava ha colaborado con la FMH en programas de capacitación médica a través del programa de becas de los Centros Internacionales de Entrenamiento en Hemofilia (CIEHEMO); ha apoyado en la elaboración del Sondeo Mundial Anual (SMA), y encabezado la preparación de todas las ediciones de las Guías de la FMH para el tratamiento de la hemofilia, incluso de la tercera edición. También ha formado parte del Comité de la FMH sobre seguridad, abasto y accesibilidad de productos de tratamiento, así como del Foro Mundial de la FMH y de las mesas redondas sobre terapia génica de la FMH.

La invaluable experiencia de Alok Srivastava como miembro médico será de gran valor para la FMH. Acompáñenos a darle la bienvenida al consejo directivo de la FMH.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.